The Relationship Between Functional Constipation and Sacroiliac Joint Dysfunction
Launched by ABANT IZZET BAYSAL UNIVERSITY · Jun 21, 2022
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the connection between chronic constipation and problems with the sacroiliac joint, which is located in the lower back and connects the spine to the pelvis. Researchers want to understand if women who experience functional constipation—constipation that doesn't have a clear medical cause—have more issues with their sacroiliac joint compared to women who do not have constipation.
To participate, women aged between 65 and 74 who meet the criteria for functional constipation can join the study, as long as they haven't used laxatives in the past four weeks. There is also a control group for women who do not have constipation. Participants will help researchers learn more about this relationship, which could lead to better treatments for those affected by chronic constipation. It's important to note that certain conditions, like pregnancy, some medications, and a variety of medical issues, would exclude someone from participating in the trial.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria (for functional constipation group):
- • Voluntary participation in the research
- • Fulfill the diagnostic criteria for functional constipation (Rome IV)
- • Being women
- • Not using laxatives for at least the last 4 weeks
- Inclusion Criteria (for control group):
- • Voluntary participation in the research
- • Being women
- • Not having functional constipation
- Exclusion Criteria:
- • Having cooperation problems
- • Being pregnant
- • Being breast-feeding
- • Taking medication for depression, hypertension, sleep disorders, and pain
- • Having parkinson, stroke, spinal cord injury, multiple sclerosis, hypothyroidism, Diabetes Mellitus, cerebral Palsy, thyroid problems, cancer, presence of tumor, presence of hernia, endometriosis, neuropathy, myopathy, scleroderma, inflammatory bowel diseases (Crohn, gastrointestinal tuberculosis, celiac, colon diverticulum, colonoscopy), cognitive impairment
- • Having neurological or metabolic or malignant disorders
- • Having a history of open abdominal surgery
- • Having a history of pelvic and abdominal radiotherapy
About Abant Izzet Baysal University
Abant Izzet Baysal University is a prominent academic institution located in Turkey, dedicated to advancing education, research, and innovation in various fields, including healthcare and clinical studies. The university actively engages in clinical trials to contribute to medical knowledge and improve patient care, leveraging its robust infrastructure and expert faculty. With a commitment to ethical research practices and collaboration with healthcare professionals, Abant Izzet Baysal University aims to enhance the understanding of diseases and develop effective therapeutic interventions, fostering a strong link between academia and clinical application.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bolu, , Turkey
Patients applied
Trial Officials
Ömer Osman Pala
Principal Investigator
Bolu Abant İzzet Baysal University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials